Neuro-Oncology Reviews
Volume
25 Number 5
15 March 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 5, 15 March
Zeng J, Zeng
XX.
Systems
Medicine for Precise Targeting of Glioblastoma Systems Medicine
Against Glioblastoma.
Mol
Biotechnol. 2023 Mar 1:1–20∟.
doi: 10.1007/s12033-023-00699-x∟.
PMID: 36859639∟.
Review. ˍ
*
Burko P, D'Amico G, Miltykh I, Scalia F, Conway de Macario E,
Macario AJL, Giglia G, Cappello F, Caruso Bavisotto C.
Molecular
Pathways Implicated in Radioresistance of Glioblastoma Multiforme:
What Is the Role of Extracellular Vesicles?
Int
J Mol Sci. 2023 Mar 2;24(5):4883∟.
doi: 10.3390/ijms24054883∟.
PMID: 36902314∟.
Review. ˍ
Martin JA,
Hart NH, Bradford N, Naumann F, Pinkham MB, Pinkham EP, Holland
JJ.
Prevalence
and management of sleep disturbance in adults with primary brain
tumours and their caregivers: a systematic review.
J
Neurooncol. 2023 Mar 2∟.
doi: 10.1007/s11060-023-04270-1∟.
PMID: 36864318∟.
Review. ˍ
Xiaoxue T,
Yinzhong W, Meng Q, Lu X, Lei J.
Diagnostic
value of PET with different radiotracers and MRI for recurrent
glioma: a Bayesian network meta-analysis.
BMJ
Open. 2023 Mar 2;13(3):e062555∟.
doi: 10.1136/bmjopen-2022-062555∟.
PMID: 36863738∟.
Meta-analysis. ˍ
Hirschler L,
Sollmann N, Schmitz-Abecassis B, Pinto J, Arzanforoosh F, Barkhof
F, Booth T, Calvo-Imirizaldu M, Cassia G, Chmelik M, Clement P,
Ercan E, Fernández-Seara MA, Furtner J, Fuster-Garcia E,
Grech-Sollars M, Guven NT, Hatay GH, Karami G, Keil VC, Kim M,
Koekkoek JAF, Kukran S, Mancini L, Nechifor RE, Özcan A,
Ozturk-Isik E, Piskin S, Schmainda K, Svensson SF, Tseng CH,
Unnikrishnan S, Vos F, Warnert E, Zhao MY, Jancalek R, Nunes T,
Emblem KE, Smits M, Petr J, Hangel G.
Advanced
MR Techniques for Preoperative Glioma Characterization: Part 1.
J
Magn Reson Imaging. 2023 Mar 3∟.
doi: 10.1002/jmri.28662∟.
PMID: 36866773∟.
Review. ˍ
Wang Y, Li S, Peng Y, Ma W, Wang Y,
Li W.
Progress
in phase III clinical trials of molecular targeted therapy and
immunotherapy for glioblastoma.
Cancer
Innov. 2023 Mar 5;2(2):114-130∟.
doi: 10.1002/cai2.59∟.
PMID: 38090060∟.
Review. ˍ
Jovanovich N, Habib A, Hameed NF, Edwards L, Zinn PO.
Applications
and current challenges of chimeric antigen receptor T cells in
treating high-grade gliomas in adult and pediatric
populations.
Immunotherapy.
2023 Mar 6;15(5):383-396∟.
doi: 10.2217/imt-2022-0200∟.
PMID: 36876438∟.
Review˰ ˍ
*
Mohapatra S, Cafiero J, Kashfi K, Mehta P, Banerjee P.
Why
Don't the Mutant Cells That Evade DNA Repair Cause Cancer More
Frequently? Importance of the Innate Immune System in the Tumor
Microenvironment.
Int
J Mol Sci. 2023 Mar 6;24(5):5026∟.
doi: 10.3390/ijms24055026∟.
PMID: 36902456∟.
Review. ˍ
Sait SF, Giantini-Larsen AM, Tringale KR, Souweidane MM,
Karajannis MA.
Treatment of Pediatric
Low-Grade Gliomas.
Curr
Neurol Neurosci Rep. 2023 Mar 7∟.
doi: 10.1007/s11910-023-01257-3∟.
PMID: 36881254∟.
Review˰ ˍ
Villa GR, Chiocca EA.
The Role of Long
Noncoding RNAs in Glioblastoma: What the Neurosurgeon Should
Know.
Neurosurgery. 2023 Mar 7∟.
doi: 10.1227/neu.0000000000002449∟.
PMID: 36880757∟.
Review˰
ˍ
Ardizzone A, Basilotta R, Filippone A, Crupi L, Lanza M, Lombardo
SP, Colarossi C, Sciacca D, Cuzzocrea S, Esposito E, Campolo
M.
Recent Emerging Immunological
Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting
Immunotherapies.
Cells.
2023 Mar 8;12(6):841∟.
doi: 10.3390/cells12060841∟.
PMID: 36980182∟.
Review.
ˍ
Viaene AN.
Pediatric brain tumors: A
neuropathologist's approach to the integrated diagnosis.
Front
Pediatr. 2023 Mar 8;11:1143363∟.
doi: 10.3389/fped.2023.1143363∟.
PMID: 36969278∟.
Review.
ˍ
Wu L, Chai R, Lin Z, Wu R, Yao D, Jiang T, Wang
Q.
Evolution-driven crosstalk between
glioblastoma and the tumor microenvironment.
Cancer
Biol Med. 2023 Mar 8:j.issn.2095-3941.2022.0771∟.
doi: 10.20892/j.issn.2095-3941.2022.0771∟.
PMID: 36880534∟.
Perspective. ˍ
Zhang S, Ni Q.
Prognostic role of the
pretreatment systemic immune-inflammation index in patients with
glioma: A meta-analysis.
Front
Neurol. 2023 Mar 8;14:1094364∟.
doi: 10.3389/fneur.2023.1094364∟.
PMID: 36970508∟.
Meta-analysis. ˍ
Orzan OA, Giurcăneanu C, Dima B, Dima MB, Ion A, Bălăceanu
B, Nițipir C, Tudose I, Nicolae CA, Dorobanțu
AM.
Cutaneous Melanoma and Glioblastoma
Multiforme Association-Case Presentation and Literature
Review.
Diagnostics
(Basel). 2023 Mar 9;13(6):1046∟.
doi: 10.3390/diagnostics13061046∟.
PMID: 36980355∟.
Case report, Review. ˍ
Dellaretti M, Melo MT, Faraj de Lima FB, Guazzelli S, Costa BBR,
Pereira PSS, Torres RE.
Fluorescein-guided
surgery for malignant gliomas.
World
Neurosurg. 2023 Mar 10:S1878-8750(23)00294-2∟.
doi: 10.1016/j.wneu.2023.02.144∟.
PMID: 36906086∟.
Review, Video article˰ ˍ
Duffau H.
Oncological and functional
neurosurgery: Perspectives for the decade regarding diffuse
gliomas.
Rev
Neurol (Paris). 2023 Mar 10:S0035-3787(23)00861-5∟.
doi: 10.1016/j.neurol.2023.01.724∟.
PMID: 36907710∟.
Review˰ ˍ
Huang X, Shi S, Wang H, Zhao T, Wang Y, Huang S, Su Y, Zhao C,
Yang M.
Advances in antibody-based
drugs and their delivery through the blood-brain barrier for
targeted therapy and immunotherapy of gliomas.
Int
Immunopharmacol. 2023 Mar 10;117:109990∟.
doi: 10.1016/j.intimp.2023.109990∟.
PMID: 37012874∟.
Review˰
ˍ
*
Natale G, Fini E, Calabrò PF, Carli M, Scarselli M, Bocci
G.
Valproate and lithium: Old drugs for
new pharmacological approaches in brain tumors?
Cancer
Lett. 2023 Mar 11;560:216125∟.
doi: 10.1016/j.canlet.2023.216125∟.
PMID: 36914086∟.
Review˰ ˍ
Cruz N, Herculano-Carvalho M, Roque D, Faria CC, Cascão R,
Ferreira HA, Reis CP, Matela N.
Highlighted
Advances in Therapies for Difficult-To-Treat Brain Tumours Such as
Glioblastoma.
Pharmaceutics.
2023 Mar 13;15(3):928∟.
doi: 10.3390/pharmaceutics15030928∟.
PMID: 36986790∟.
Review. ˍ
Hangel G, Schmitz-Abecassis B, Sollmann N, Pinto J, Arzanforoosh
F, Barkhof F, Booth T, Calvo-Imirizaldu M, Cassia G, Chmelik M,
Clement P, Ercan E, Fernández-Seara MA, Furtner J,
Fuster-Garcia E, Grech-Sollars M, Guven NT, Hatay GH, Karami G,
Keil VC, Kim M, Koekkoek JAF, Kukran S, Mancini L, Nechifor RE,
Özcan A, Ozturk-Isik E, Piskin S, Schmainda KM, Svensson SF,
Tseng CH, Unnikrishnan S, Vos F, Warnert E, Zhao MY, Jancalek R,
Nunes T, Hirschler L, Smits M, Petr J, Emblem KE.
Advanced
MR Techniques for Preoperative Glioma Characterization: Part 2.
J
Magn Reson Imaging. 2023 Mar 13∟.
doi: 10.1002/jmri.28663∟.
PMID: 36912262∟.
Review. ˍ
*
Reiter RJ, Sharma R, Cucielo MS, Tan DX, Rosales-Corral S,
Gancitano G, de Almeida Chuffa LG.
Brain
washing and neural health: role of age, sleep, and the
cerebrospinal fluid melatonin rhythm.
Cell Mol Life
Sci. 2023 Mar 14;80(4):88∟.
doi: 10.1007/s00018-023-04736-5?
PMID: 36917314∟.
Review˰
ˍ
Asija S, Chatterjee A, Goda JS,
Yadav S, Chekuri G, Purwar R.
Oncolytic
immunovirotherapy for high-grade gliomas: A novel and an evolving
therapeutic option.
Front
Immunol. 2023 Mar 15;14:1118246∟.
doi: 10.3389/fimmu.2023.1118246∟.
PMID: 37006286∟.
Review.
ˍ
Casciati A, Mancuso M, Vitali R, Pazzaglia S.
Gut-brain
axis: does intestinal inflammation affect hippocampal neurogenesis
and medulloblastoma development?
Neural
Regen Res. 2023 Mar 15;18(11):2381-2382∟.
doi: 10.4103/1673-5374.371353∟.
PMID: 37282458∟.
Perspective. ˍ
Wach J, Vychopen M, Kühnapfel A, Seidel C, Güresir E.
A
Systematic Review and Meta-Analysis of Supramarginal Resection
versus Gross Total Resection in Glioblastoma: Can We Enhance
Progression-Free Survival Time and Preserve Postoperative
Safety?
Cancers
(Basel). 2023 Mar 15;15(6):1772∟.
doi: 10.3390/cancers15061772∟.
PMID: 36980659∟.
Review. ˍ